General Information of Drug Off-Target (DOT) (ID: OTHCGIEZ)

DOT Name Forkhead box protein P4 (FOXP4)
Synonyms Fork head-related protein-like A
Gene Name FOXP4
Related Disease
Advanced cancer ( )
Breast carcinoma ( )
Bone osteosarcoma ( )
Breast cancer ( )
Ewing sarcoma ( )
Kidney neoplasm ( )
Laryngeal carcinoma ( )
Lung adenocarcinoma ( )
Neoplasm ( )
Non-small-cell lung cancer ( )
Osteoarthritis ( )
Osteosarcoma ( )
Prostate carcinoma ( )
Renal carcinoma ( )
Renal cell carcinoma ( )
Hepatocellular carcinoma ( )
Asthma ( )
Prostate cancer ( )
Prostate neoplasm ( )
Squamous cell carcinoma ( )
UniProt ID
FOXP4_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
PDB ID
6XAT
Pfam ID
PF00250 ; PF16159
Sequence
MMVESASETIRSAPSGQNGVGSLSGQADGSSGGATGTTASGTGREVTTGADSNGEMSPAE
LLHFQQQQALQVARQFLLQQASGLSSPGNNDSKQSASAVQVPVSVAMMSPQMLTPQQMQQ
ILSPPQLQALLQQQQALMLQQLQEYYKKQQEQLHLQLLTQQQAGKPQPKEALGNKQLAFQ
QQLLQMQQLQQQHLLNLQRQGLVSLQPNQASGPLQTLPQAAVCPTDLPQLWKGEGAPGQP
AEDSVKQEGLDLTGTAATATSFAAPPKVSPPLSHHTLPNGQPTVLTSRRDSSSHEETPGS
HPLYGHGECKWPGCETLCEDLGQFIKHLNTEHALDDRSTAQCRVQMQVVQQLEIQLAKES
ERLQAMMAHLHMRPSEPKPFSQPLNPVPGSSSFSKVTVSAADSFPDGLVHPPTSAAAPVT
PLRPPGLGSASLHGGGPARRRSSDKFCSPISSELAQNHEFYKNADVRPPFTYASLIRQAI
LETPDRQLTLNEIYNWFTRMFAYFRRNTATWKNAVRHNLSLHKCFVRVENVKGAVWTVDE
REYQKRRPPKMTGSPTLVKNMISGLSYGALNASYQAALAESSFPLLNSPGMLNPGSASSL
LPLSHDDVGAPVEPLPSNGSSSPPRLSPPQYSHQVQVKEEPAEAEEDRQPGPPLGAPNPS
ASGPPEDRDLEEELPGEELS
Function Transcriptional repressor that represses lung-specific expression.

Molecular Interaction Atlas (MIA) of This DOT

20 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Advanced cancer DISAT1Z9 Definitive Biomarker [1]
Breast carcinoma DIS2UE88 Definitive Altered Expression [1]
Bone osteosarcoma DIST1004 Strong Biomarker [2]
Breast cancer DIS7DPX1 Strong Altered Expression [1]
Ewing sarcoma DISQYLV3 Strong Biomarker [3]
Kidney neoplasm DISBNZTN Strong Biomarker [4]
Laryngeal carcinoma DISNHCIV Strong Altered Expression [4]
Lung adenocarcinoma DISD51WR Strong Genetic Variation [5]
Neoplasm DISZKGEW Strong Altered Expression [6]
Non-small-cell lung cancer DIS5Y6R9 Strong Altered Expression [7]
Osteoarthritis DIS05URM Strong Biomarker [8]
Osteosarcoma DISLQ7E2 Strong Biomarker [2]
Prostate carcinoma DISMJPLE Strong Genetic Variation [9]
Renal carcinoma DISER9XT Strong Altered Expression [10]
Renal cell carcinoma DISQZ2X8 Strong Altered Expression [10]
Hepatocellular carcinoma DIS0J828 moderate Biomarker [6]
Asthma DISW9QNS Limited Biomarker [11]
Prostate cancer DISF190Y Limited Altered Expression [12]
Prostate neoplasm DISHDKGQ Limited Biomarker [13]
Squamous cell carcinoma DISQVIFL Limited Biomarker [14]
------------------------------------------------------------------------------------
⏷ Show the Full List of 20 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
7 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate decreases the expression of Forkhead box protein P4 (FOXP4). [15]
Acetaminophen DMUIE76 Approved Acetaminophen increases the expression of Forkhead box protein P4 (FOXP4). [16]
Doxorubicin DMVP5YE Approved Doxorubicin decreases the expression of Forkhead box protein P4 (FOXP4). [17]
Cupric Sulfate DMP0NFQ Approved Cupric Sulfate increases the expression of Forkhead box protein P4 (FOXP4). [18]
Estradiol DMUNTE3 Approved Estradiol decreases the expression of Forkhead box protein P4 (FOXP4). [19]
Urethane DM7NSI0 Phase 4 Urethane increases the expression of Forkhead box protein P4 (FOXP4). [21]
PMID28460551-Compound-2 DM4DOUB Patented PMID28460551-Compound-2 increases the expression of Forkhead box protein P4 (FOXP4). [24]
------------------------------------------------------------------------------------
⏷ Show the Full List of 7 Drug(s)
6 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Arsenic DMTL2Y1 Approved Arsenic affects the methylation of Forkhead box protein P4 (FOXP4). [20]
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene decreases the methylation of Forkhead box protein P4 (FOXP4). [22]
TAK-243 DM4GKV2 Phase 1 TAK-243 decreases the sumoylation of Forkhead box protein P4 (FOXP4). [23]
PMID28870136-Compound-52 DMFDERP Patented PMID28870136-Compound-52 affects the phosphorylation of Forkhead box protein P4 (FOXP4). [25]
Bisphenol A DM2ZLD7 Investigative Bisphenol A increases the methylation of Forkhead box protein P4 (FOXP4). [26]
Coumarin DM0N8ZM Investigative Coumarin increases the phosphorylation of Forkhead box protein P4 (FOXP4). [25]
------------------------------------------------------------------------------------
⏷ Show the Full List of 6 Drug(s)

References

1 Upregulation of FOXP4 in breast cancer promotes migration and invasion through facilitating EMT.Cancer Manag Res. 2019 Apr 8;11:2783-2793. doi: 10.2147/CMAR.S191641. eCollection 2019.
2 Up-regulation of microRNA-491-5p suppresses cell proliferation and promotes apoptosis by targeting FOXP4 in human osteosarcoma.Cell Prolif. 2017 Feb;50(1):e12308. doi: 10.1111/cpr.12308. Epub 2016 Oct 5.
3 LncRNA SOX2 overlapping transcript acts as a miRNA sponge to promote the proliferation and invasion of Ewing's sarcoma.Am J Transl Res. 2019 Jun 15;11(6):3841-3849. eCollection 2019.
4 FoxP4, a novel forkhead transcription factor.Biochim Biophys Acta. 2003 Jun 19;1627(2-3):147-52. doi: 10.1016/s0167-4781(03)00074-5.
5 Association of variations in HLA class II and other loci with susceptibility to EGFR-mutated lung adenocarcinoma.Nat Commun. 2016 Aug 9;7:12451. doi: 10.1038/ncomms12451.
6 Upregulation of FoxP4 in HCC promotes migration and invasion through regulation of EMT.Oncol Lett. 2019 Apr;17(4):3944-3951. doi: 10.3892/ol.2019.10049. Epub 2019 Feb 19.
7 FOXP4 modulates tumor growth and independently associates with miR-138 in non-small cell lung cancer cells.Tumour Biol. 2015 Sep;36(10):8185-91. doi: 10.1007/s13277-015-3498-8. Epub 2015 May 21.
8 Identification of differentially methylated regions in new genes associated with knee osteoarthritis.Gene. 2016 Jan 15;576(1 Pt 2):312-8. doi: 10.1016/j.gene.2015.10.037. Epub 2015 Oct 17.
9 12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population.Nat Commun. 2019 Sep 27;10(1):4422. doi: 10.1038/s41467-019-12267-6.
10 CircRNA ZNF609 functions as a competitive endogenous RNA to regulate FOXP4 expression by sponging miR-138-5p in renal carcinoma.J Cell Physiol. 2019 Jul;234(7):10646-10654. doi: 10.1002/jcp.27744. Epub 2018 Nov 27.
11 Epithelium-generated neuropeptide Y induces smooth muscle contraction to promote airway hyperresponsiveness.J Clin Invest. 2016 May 2;126(5):1978-82. doi: 10.1172/JCI81389. Epub 2016 Apr 18.
12 LncRNA FOXP4-AS1 is activated by PAX5 and promotes the growth of prostate cancer by sequestering miR-3184-5p to upregulate FOXP4.Cell Death Dis. 2019 Jun 17;10(7):472. doi: 10.1038/s41419-019-1699-6.
13 Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population.Nat Genet. 2010 Sep;42(9):751-4. doi: 10.1038/ng.635. Epub 2010 Aug 1.
14 MicroRNA-299-3p/FOXP4 Axis Regulates the Proliferation and Migration of Oral Squamous Cell Carcinoma.Technol Cancer Res Treat. 2019 Jan 1;18:1533033819874803. doi: 10.1177/1533033819874803.
15 Effects of lithium and valproic acid on gene expression and phenotypic markers in an NT2 neurosphere model of neural development. PLoS One. 2013;8(3):e58822.
16 Multiple microRNAs function as self-protective modules in acetaminophen-induced hepatotoxicity in humans. Arch Toxicol. 2018 Feb;92(2):845-858.
17 Bringing in vitro analysis closer to in vivo: studying doxorubicin toxicity and associated mechanisms in 3D human microtissues with PBPK-based dose modelling. Toxicol Lett. 2018 Sep 15;294:184-192.
18 Physiological and toxicological transcriptome changes in HepG2 cells exposed to copper. Physiol Genomics. 2009 Aug 7;38(3):386-401.
19 High-throughput ectopic expression screen for tamoxifen resistance identifies an atypical kinase that blocks autophagy. Proc Natl Acad Sci U S A. 2011 Feb 1;108(5):2058-63.
20 Prenatal arsenic exposure and the epigenome: identifying sites of 5-methylcytosine alterations that predict functional changes in gene expression in newborn cord blood and subsequent birth outcomes. Toxicol Sci. 2015 Jan;143(1):97-106. doi: 10.1093/toxsci/kfu210. Epub 2014 Oct 10.
21 Ethyl carbamate induces cell death through its effects on multiple metabolic pathways. Chem Biol Interact. 2017 Nov 1;277:21-32.
22 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
23 Inhibiting ubiquitination causes an accumulation of SUMOylated newly synthesized nuclear proteins at PML bodies. J Biol Chem. 2019 Oct 18;294(42):15218-15234. doi: 10.1074/jbc.RA119.009147. Epub 2019 Jul 8.
24 Cell-based two-dimensional morphological assessment system to predict cancer drug-induced cardiotoxicity using human induced pluripotent stem cell-derived cardiomyocytes. Toxicol Appl Pharmacol. 2019 Nov 15;383:114761. doi: 10.1016/j.taap.2019.114761. Epub 2019 Sep 15.
25 Quantitative phosphoproteomics reveal cellular responses from caffeine, coumarin and quercetin in treated HepG2 cells. Toxicol Appl Pharmacol. 2022 Aug 15;449:116110. doi: 10.1016/j.taap.2022.116110. Epub 2022 Jun 7.
26 DNA methylome-wide alterations associated with estrogen receptor-dependent effects of bisphenols in breast cancer. Clin Epigenetics. 2019 Oct 10;11(1):138. doi: 10.1186/s13148-019-0725-y.